Articles for tag: 65M, Critical, Diagnosis, diseases, Expand, Funding, Globally, Health, Qure.ai, Revolutionizing, Secures, Solutions, Treatment

Market News

Qure.ai secures M funding to expand AI health solutions globally, revolutionizing diagnosis and treatment in critical diseases.

Qure.ai secures $65M funding to expand AI health solutions globally, revolutionizing diagnosis and treatment in critical diseases.

Qure.ai, an innovative healthtech company based in Mumbai, has successfully raised $65 million in a Series D funding round. This investment will help accelerate its expansion into the U.S. and other markets, improve its foundational AI models, and support potential acquisitions in the med-tech space. Founded in 2016, Qure.ai aims to make healthcare more accessible ...

Market News

MK Stalin Slams Sitharaman for ‘Shameful’ Treatment of Businessman, Sparking GST Controversy and Public Outcry

Tamil Nadu Chief Minister MK Stalin has condemned Union Finance Minister Nirmala Sitharaman for her behavior towards a Coimbatore businessman who raised concerns about the Goods and Services Tax (GST). The businessman, D Srinivasan, owner of Sri Annapoorna restaurant, was seen in a viral video apologizing to Sitharaman after discussing the complexities of GST on ...

Market News

Akums Drugs secures a patent for a novel Hydroxyurea formulation, promising affordable treatment for Sickle Cell Disease and enhancing patient care.

Akums Drugs secures a patent for a novel Hydroxyurea formulation, promising affordable treatment for Sickle Cell Disease and enhancing patient care.

Akums Drugs and Pharmaceuticals has announced that it has received a patent from the Indian patent office for an innovative formulation aimed at treating Sickle Cell Disease (SCD). This new oral suspension of Hydroxyurea is designed to be stable at room temperature, making it easier for patients to manage this genetic blood disorder that causes ...

Market News

Amazon and Flipkart face antitrust findings in India for preferential treatment of sellers, igniting a fierce competition debate.

Amazon and Flipkart face antitrust findings in India for preferential treatment of sellers, igniting a fierce competition debate.

An Indian antitrust investigation has concluded that Amazon and Flipkart violated local competition laws by favoring specific sellers on their platforms. The Competition Commission of India (CCI) initiated this probe in 2020, following complaints that these companies promoted select sellers over others. The findings revealed that preferred sellers appeared more prominently in search results, marginalizing ...

Market News

Allegations of corruption swirl around Sebi chairperson Madhabi Puri Buch as Congress claims her husband received preferential treatment from Mahindra.[embed]https://www.youtube.com/watch?v=tN-pxlKfJAI[/embed]

Allegations of corruption swirl around Sebi chairperson Madhabi Puri Buch as Congress claims her husband received preferential treatment from Mahindra.

Madhabi Puri Buch, chairperson of Sebi, is facing allegations from the Congress party that her husband, Dhaval Buch, received substantial payments from Mahindra & Mahindra while Sebi was regulating the company. Mahindra denied these claims, stating Dhaval was hired for his supply chain expertise before Madhabi took office at Sebi. They emphasized that they never ...

Market News

Breakthrough Cancer Treatment IMDELLTRA™ Approved by FDA – Hope for Small Cell Lung Cancer Patients! | Amgen

The FDA has granted approval to Amgen for their groundbreaking new treatment, Imdeltra™ (tarlatamab-dllE), making it the first and only T-cell engager therapy available for extensive-stage small cell lung cancer. This innovative therapy offers hope for patients battling this aggressive form of cancer, providing a much-needed treatment option for those in need. Click to Claim ...

DeFi Explained: Simple Guide Green Crypto and Sustainability China’s Stock Market Rally and Outlook The Future of NFTs The Rise of AI in Crypto